Literature DB >> 21429575

The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation.

Stanley J Stachelek1, Matthew J Finley, Ivan S Alferiev, Fengxiang Wang, Richard K Tsai, Edward C Eckells, Nancy Tomczyk, Jeanne M Connolly, Dennis E Discher, David M Eckmann, Robert J Levy.   

Abstract

CD47 is a transmembrane protein that is a marker of "self". CD47 binding to its cognate receptor in leukocytes and macrophages, signal-regulatory protein alpha (SIRPα), causes inhibition of inflammatory cell attachment. We hypothesized that immobilization of recombinant CD47 on polymeric surfaces would reduce inflammation. Recombinant CD47 was appended to polyvinyl chloride (PVC) or polyurethane (PU) surfaces via photoactivation chemistry. Cell culture studies showed that CD47 immobilization significantly reduced human neutrophil (HL-60) and human monocyte derived macrophage (MDM) (THP-1) attachment to PVC and PU respectively. A neutralizing antibody, directed against SIRPα, inhibited THP-1 and HL-60 binding to PU and PVC surfaces respectively. This antibody also increased the level of SIRPα tyrosine phosphorylation, thereby indicating a direct role for SIRPα mediated signaling in preventing inflammatory cell attachment. Studies using human blood in an ex vivo flow-loop showed that CD47 modified PVC tubing significantly reduced cell binding and neutrophil activation compared to unmodified tubing or poly-2-methoxy-ethylacrylate (PMEA) coated tubing. In ten-week rat subdermal implants, CD47 functionalized PU films showed a significant reduction in markers of MDM mediated oxidative degradation compared to unmodified PU. In conclusion, CD47 functionalized surfaces can resist inflammatory cell interactions both in vitro and in vivo.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429575      PMCID: PMC3108143          DOI: 10.1016/j.biomaterials.2011.02.053

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  38 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

Review 3.  Inflammatory response to cardiopulmonary bypass.

Authors:  L H Edmunds
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

Review 4.  Integrin-associated protein (CD47) and its ligands.

Authors:  E J Brown; W A Frazier
Journal:  Trends Cell Biol       Date:  2001-03       Impact factor: 20.808

5.  A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standby.

Authors:  Ann Karimova; Alex Robertson; Nigel Cross; Liz Smith; Maura O'callaghan; Catherine Tuleu; Paul Long; Allison Beeton; Jihong Han; Deborah Ridout; Allan Goldman; Kate Brown
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation.

Authors:  T Yoshizaki; N Tabuchi; W van Oeveren; A Shibamiya; T Koyama; M Sunamori
Journal:  Int J Artif Organs       Date:  2005-08       Impact factor: 1.595

8.  CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1.

Authors:  E F Vernon-Wilson; W J Kee; A C Willis; A N Barclay; D L Simmons; M H Brown
Journal:  Eur J Immunol       Date:  2000-08       Impact factor: 5.532

Review 9.  Role of CD47 in erythroid cells and in autoimmunity.

Authors:  Per-Arne Oldenborg
Journal:  Leuk Lymphoma       Date:  2004-07

10.  Expression of an activated form of integrin beta2 chain CD18 in cardiac surgical operations.

Authors:  Manuela Kudlová; Martina Kolácková; Pavel Kunes; Vladimír Lonský; Jirí Mand'ák; Andrýs Ctirad; Jan Krejsek
Journal:  Acta Medica (Hradec Kralove)       Date:  2007
View more
  27 in total

1.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

2.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

3.  Enhanced biocompatibility of CD47-functionalized vascular stents.

Authors:  Joshua B Slee; Ivan S Alferiev; Chandrasekaran Nagaswami; John W Weisel; Robert J Levy; Ilia Fishbein; Stanley J Stachelek
Journal:  Biomaterials       Date:  2016-02-08       Impact factor: 12.479

4.  Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles.

Authors:  Pia L Rodriguez; Takamasa Harada; David A Christian; Diego A Pantano; Richard K Tsai; Dennis E Discher
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

5.  Stabilization of dry protein coatings with compatible solutes.

Authors:  Manuela S Killian; Adam J Taylor; David G Castner
Journal:  Biointerphases       Date:  2018-06-29       Impact factor: 2.456

6.  The use of the ex vivo Chandler Loop Apparatus to assess the biocompatibility of modified polymeric blood conduits.

Authors:  Joshua B Slee; Ivan S Alferiev; Robert J Levy; Stanley J Stachelek
Journal:  J Vis Exp       Date:  2014-08-20       Impact factor: 1.355

Review 7.  The use of CD47-modified biomaterials to mitigate the immune response.

Authors:  Jillian E Tengood; Robert J Levy; Stanley J Stachelek
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

8.  Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance.

Authors:  Joshua Kim; Sauradeep Sinha; Melani Solomon; Edgar Perez-Herrero; Janet Hsu; Zois Tsinas; Silvia Muro
Journal:  Biomaterials       Date:  2017-09-06       Impact factor: 12.479

9.  Correlating macrophage morphology and cytokine production resulting from biomaterial contact.

Authors:  Hyun-Su Lee; Stanley J Stachelek; Nancy Tomczyk; Matthew J Finley; Russell J Composto; David M Eckmann
Journal:  J Biomed Mater Res A       Date:  2012-07-30       Impact factor: 4.396

10.  Hyaluronan and dextran modified tubes resist cellular activation with blood contact.

Authors:  David M Eckmann; Irene Y Tsai; Nancy Tomczyk; John W Weisel; Russell J Composto
Journal:  Colloids Surf B Biointerfaces       Date:  2013-02-26       Impact factor: 5.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.